These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1859146)

  • 1. [Heparin and the arterial wall].
    Manciet G; Decamps A; Bourdel I; Emeriau JP; Galley P
    Ann Cardiol Angeiol (Paris); 1991 Jun; 40(6):385-9. PubMed ID: 1859146
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of smooth muscle proliferation by heparin in vitro and in vivo.
    Clowes AW; Clowes MM
    Int Angiol; 1987; 6(1):45-51. PubMed ID: 3624946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiatherogenic action of heparin].
    Stajszczyk M; Gmiński J
    Postepy Hig Med Dosw; 1994; 48(3):275-90. PubMed ID: 7971602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin, polycations, and atherosclerosis.
    Hyslop S; de Nucci G
    Semin Thromb Hemost; 1993; 19(2):89-98. PubMed ID: 8356463
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cultivated human vascular wall cells. A model for discovering potentially anti-arteriosclerosis active substances?].
    Roth D; Betz E
    Vasa Suppl; 1992; 35():125-7. PubMed ID: 1282737
    [No Abstract]   [Full Text] [Related]  

  • 6. [Review: heparin. 2. Effect on thrombocytes, vascular walls and fibrinolysis].
    Kase F; Pospísil J; Hlousková D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):905-15. PubMed ID: 1713897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of heparin in the atherosclerotic process.
    Engelberg H
    Pharmacol Rev; 1996 Jun; 48(2):327-52. PubMed ID: 8804108
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the mechanisms of the antiatherogenic effect of Ca-antagonists].
    Birou S
    Igaku Kenkyu; 1988 Apr; 58(2):77-84. PubMed ID: 3245408
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of anti-atherosclerotic substances on smooth muscle cell migration and proliferation analyzed by time-lapse video microscopy.
    Grünwald J
    Int Angiol; 1987; 6(1):59-64. PubMed ID: 3624949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of diltiazem on plaque cells of primary and restenosed lesions].
    Voisard R; Dartsch PC; Bauriedel G; Höfling B; Betz E
    Vasa Suppl; 1989; 27():241-3. PubMed ID: 2623504
    [No Abstract]   [Full Text] [Related]  

  • 11. Different inhibitory effects of immunosuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor.
    Mohacsi PJ; Tüller D; Hulliger B; Wijngaard PL
    J Heart Lung Transplant; 1997 May; 16(5):484-92. PubMed ID: 9171265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans.
    Majack RA; Clowes AW
    J Cell Physiol; 1984 Mar; 118(3):253-6. PubMed ID: 6699099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacologic inhibition of experimental atherosclerosis].
    Seuter F
    Z Kardiol; 1989; 78 Suppl 6():117-9. PubMed ID: 2618127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of cicletanine on the mechanical properties of the arterial wall].
    Levy BI; Poitevin P; Safar ME
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():67-70. PubMed ID: 2514672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-independent mitogenicity in an endothelial and smooth muscle cell chimeric growth factor (S130K-HBGAM).
    Brewster LP; Brey EM; Tassiopoulos AK; Xue L; Maddox E; Armistead D; Burgess WH; Greisler HP
    Am J Surg; 2004 Nov; 188(5):575-9. PubMed ID: 15546573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cysteine-free fibroblast growth factor 1 mutant induces heparin-independent proliferation of endothelial cells and smooth muscle cells.
    Xue L; Shireman PK; Hampton B; Burgess WH; Greisler HP
    J Surg Res; 2000 Aug; 92(2):255-60. PubMed ID: 10896831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathomechanisms of atherosclerosis beneficially affected by prostaglandin E1 (PGE1)--an update.
    Sinzinger H; Virgolini I; Fitscha P
    Vasa Suppl; 1989; 28():6-13. PubMed ID: 2692201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of endothelium-dependent responses to acetylcholine in canine femoral arteries and veins. Separation of the role played by endothelial and smooth muscle cells.
    Rubanyi GM; Vanhoutte PM
    Blood Vessels; 1988; 25(2):75-81. PubMed ID: 3257889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Methods for exploring arteries in humans: application to the study of estrogens].
    Laurent S; Boutouyrie P
    Therapie; 1999; 54(3):347-52. PubMed ID: 10500449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboresistance of the arterial wall: the role of heparin and glycosaminoglycans.
    Bianciardi G; Frigidi E; Palummo N; Simoes C; Tanganelli P; Weber G
    Wien Klin Wochenschr; 1991; 103(14):412-5. PubMed ID: 1926868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.